Order Retatrutide in 10, 20 and 30 mg online at Invus Labs. See prices and stock status. For laboratory research only, not for human use.

30 mg · SEK 1,499
All peptides · Shipping and delivery
Retatrutide is a synthetic peptide also described by the research code LY3437943. This page brings together its molecular background and the quantity variants listed in the catalog.
The original research describes Retatrutide as one peptide with activity at three receptor types: GIP, GLP-1 and glucagon. The term triple agonist refers to these targets, rather than a bottle containing three separate peptides.
The research code LY3437943 helps identify original publications about the same molecule. When comparing Retatrutide with Tirzepatide, both the substance name and receptor description matter; a shared quantity unit does not make them identical substances.
An mg variant gives a stated amount of material. A solution concentration also requires a volume, so mg and mg/ml answer different questions.
The product name identifies the molecule and the variant identifies the pack quantity. Retain both when comparing products or registering material in a laboratory inventory.
It is the research code used for Retatrutide in original studies and helps locate publications about the right molecule.
No. Triple agonist describes three receptor targets of a single peptide, rather than a list of three separate ingredients.
Listed variants: 10 mg / 20 mg / 30 mg. The quantity belongs to each product variant; current availability is shown in the variant selector.
LY3437943, three receptor targets and the difference between quantity and concentration.
Distinguish pack quantity, mass concentration and amount of substance when reading material information.
Read structural models, cell responses and EC50 using a Retatrutide receptor study as an example.
The role of peptide materials in laboratory research.
How molecular identity and mass are examined in analytical work.
For laboratory research only. Not for human or veterinary use.